Edwards Lifesciences has grown revenue 15% a year over three years and 5.8% a year over five, with earnings per share compounding at −8.3%. Revenue growth, 3-year annual rate: +15% (Medical Devices median +9.2%). Revenue growth, 5-year rate: +5.8%, growth has picked up over the last three years. Earnings per share, 3-year rate: −8.3%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 18, FY2008 to FY2025, as filed.

EWEdwards Lifesciences

HealthcareUSD

$90.77

$72.6552 weeks$93.68

Is it growing?

Is EW growing?

Edwards Lifesciences has grown revenue 15% a year over three years and 5.8% a year over five, with earnings per share compounding at −8.3%.

+15%

Revenue growth, 3-year annual rate · Medical Devices median +9.2% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +5.8%
Revenue growth, 5-year rate · +15% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: −8.3%
Earnings per share, 3-year rate · revenue +15% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed